Penney's holiday strategy focuses on driving traffic into stores and restoring faith in the brand with six straight weeks of promotions ��a leap from Johnson's emphasis on everyday low prices. Low prices will be emphasized through music in the "Jingle More Bells" campaign, including the release of a new TV spot every week through the end of December. The spots will feature twists on classic holiday songs to promote in-store sales.
The first spot features a play on "Santa Baby," where carolers urge Santa to "slip a discount under the tree."
Blake Shelton, the JCP Cares ambassador, will perform at the Manhattan Mall store on Dec. 19. The event is a part of the retailer's social media campaign that allows customers to upload a video of themselves singing "Silent Night" to be featured in a virtual holiday performance on the same day.
5 Best Recreation Stocks To Buy For 2015: McEwen Mining Inc (MUX)
McEwen Mining Inc. (McEwen Mining), formerly US Gold Corporation, is engaged in the exploration for and production of precious metals in the United States, Mexico and Argentina. McEwen Mining�� operating segments include USA and Mexico. The Company holds an interest in numerous exploration and development stage properties and projects in Nevada, Mexico and Argentina, as well as a 49% equity interest in the gold-silver San Jose Mine in Santa Cruz Province, Argentina. The Company holds interests in approximately 1,631 square miles of mineral concessions in west central Mexico. Its primary property in Mexico is the El Gallo Complex, located in Sinaloa state on the Sierra Madre Trend, a geological area of gold and silver mineralization. The Company holds interests in approximately 254 square miles in Nevada, United States. The Company�� Nevada properties, including its interests in the Gold Bar Project and Tonkin Complex, are located along the Cortez Trend, in north central Nevada. It also owns property, including the Limo Project, on the southern end of the Carlin Trend. On January 24, 2012, it acquired of Minera Andes Inc. (Minera Andes).
On January 24, 2012, the Company acquired a 49% interest in Minera Santa Cruz SA, owner of the San Jose Silver-Gold Mine in Santa Cruz, Argentina; a 100% interest in the Los Azules Copper Deposit in San Juan, Argentina, and a portfolio of exploration properties in Santa Cruz, Argentina. The San Jose Mine is operated by the majority owner of the joint venture, Hochschild Mining plc (Hochschild). The Company holds mineral rights and applications for mineral rights covering approximately 944 square miles in Argentina.
Tonkin Complex
The Tonkin Complex is divided functionally into five areas: the Mine Corridor, Tonkin North, Patty, Keystone and Tweed. The Tonkin Complex represents its holding in the State of Nevada at approximately 93 square miles (241 square kilometers). The Tonkin Complex is located on the Cortez Trend. During ! the year ended December 31, 2011, the Company drilled one hole, and 2,190 feet reverse circulation drilling. The Tonkin Complex also includes the Patty Project. On October 18, 2011, Barrick Gold U.S. Inc. (Barrick), the former holder of a majority of the project and operator, entered into a joint venture agreement with Rye Patch Gold U.S. Inc. (Rye Patch) under which Rye Patch has the right to acquire a 60% undivided interest in the Patty Project. As of December 31, 2011, it held a non-operating minority interest (12%). The Patty Project is a property (approximately 18.1 square miles) located in the northeast portion of the Tonkin Complex and consists of 544 unpatented mining claims. The 372 claims (included in the 1,478 under US Gold's Historic Tonkin Property) covering the area of the property, Tonkin North were previously owned by unaffiliated parties and held by the Company under a lease agreement. The lease expired on January 1, 2011. In July 2011, it acquired these claims. The Company held an interest of in 106 claims (included in the 156 under Cornerstone) in the Cornerstone property. On July 19, 2011, it acquired the Tonkin North and Cornerstone claims.
Gold Bar Complex
The Gold Bar Complex is located south of the Tonkin Complex on the continuation of the Cortez Trend. In November 2011, the Company announced the completion of a Preliminary Feasibility Study (PFS) by SRK Consulting for the Gold Bar Project. Exploration drilling at the Gold Bar Complex in 2011 totaled approximately 7,245 feet (2,208 meters) in 41 reverse circulation drill holes that were focused on extensions to the Gold Pick-Gold Ridge and Cabin Creek mineralization, as well as targets found by geologic mapping and sampling.
The Gold Pick-Gold Ridge area occurs on the Battle Mountain-Eureka mineral belt in a window of lower-plate carbonate rocks surrounded by upper-plate rocks. The lower-plate carbonates at Gold Pick-Gold Ridge consist of an east-dipping section of Silurian Lone Mountain Do! lomite, D! evonian McColley Canyon Formation, Devonian Denay Formation, and Devonian Devils Gate Limestone. Northwest-trending and northeast-trending structures cut the area; the Gold Pick mineralization is localized in an apparent northwest-trending horst of McColley Canyon Formation, which is cut by a series of northeast-trending structures.
Limo Property
The Limo Property is located in east-central Nevada. The Limo Property position totals approximately 44.5 square miles (115 square kilometers). Gold mineralization has been identified in numerous places along the 15 mile (24 kilometers) length of the property. Exploration drilling at the Limo Property in 2011 totaled approximately 59,157 ft. (18,031 meters) in 10 diamond drill core holes and 70 reverse circulation drill holes. The drilling was focused on two targets, Cadillac and Continental, outside the existing mineralization. The mineral interests controlled by the Company at the Limo property consist of 1,392 contiguous claims that cover approximately 44.5 square miles (115 square kilometers), plus 15 claims (for a total of 1,407) near the southern boundary of the property that were acquired through a lease in August 2011. Its land package extends for about 15 miles (24 kilometers), and covers the western side of the southern Cherry Creek Range.
Battle Mountain Complex
The Battle Mountain Complex is located within Humboldt and Lander Counties in the valleys and on the flanks of the mountains surrounding Battle Mountain on the Cortez Trend north of our Tonkin complex. Battle Mountain, Nevada. In 2011, exploration drilling in the Battle Mountain Complex totaled 2,205 feet (672 meters). Work during 2011, also included geologic mapping, soil and rock sampling. Results of this work identified two target areas, Medea and Lucky Strike, on its BMX property. Three holes were drilled on the Medea prospect during 2011.
Other United States Properties
The Company acquired additional mineral! properti! es in Nevada. The mineral properties included in the acquisition of Tone (Roberts Creek, Kobeh, Gold Bar North, South Keystone, Big Antelope Springs, Red Ridge, Fish Creek and Kent Springs) are generally subject to a 1% net smelter return royalty interest in favor of KM Exploration Ltd. Certain properties (Roberts Creek, Kobeh, Gold Bar North, South Keystone and Big Antelope Springs) are also subject to earn-in rights in favor of Teck Cominco American Incorporated (Teck).
Alaska
On July 1, 2011, its Company and Select Resources Corporation, Inc. (Select) signed a four-year Exploration Lease and Purchase Option Definitive Agreement (the Definitive Agreement) with respect to the Richardson Mineral Project (Richardson) in the Tintina Gold Belt of Alaska. Under the terms of the Definitive Agreement, it acquired an exploration lease for the Richardson project, and an exclusive option to purchase a 60% interest in the project and enter into a joint venture with Select. The Richardson project is located 70 miles (115 kilometers) southeast of Fairbanks, Alaska, and covers an area of approximately 52 square miles (136 square kilometers). Extensive field sampling and mapping, airborne geophysics, and three core holes were completed in 2011. Drilling at the Richardson Project in Alaska during 2011, included three holes and 2, 863 feet core drilling.
Mexican Properties
The Company has a property in Mexico, called the El Gallo Complex, which includes the El Gallo, Magistral, and Palmarito deposits in Sinaloa state. The Company control mineral concessions of approximately 1,631 square miles (4,224 square kilometers) located in the Mexican states of Sinaloa and Nayarit. It holds its interests through ownership of Pangea Resources Inc., which in turn holds 100% ownership of Compania Minera Pangea S.A. de C.V. (Minera Pangea). The El Gallo Complex is located in Sinaloa state, northwestern Mexico in Mocorito Municipality. The El Gallo Complex is being developed in tw! o phases.! The El Gallo Project lies within two of its controlled concessions, Rocio Fraccion A and Pangea. These concessions have an area of 86,764 acres and 3,946 acres respectively. It controls the properties immediately surrounding El Gallo. Exploration work completed in 2011 at El Gallo consisted of core and conventional rotary drilling. The mineralization at the Magistral Mine Property is classified as a low-sulfidation epithermal gold-silver mineral system. During 2011, 203 core holes were drilled for a total of 88,891 feet (26,088 meters).
Other Exploration Areas
During 2011, it drill-tested a number of prospective exploration targets throughout the El Gallo district, which resulted in the discovery of four new veins. Three veins, Los Mautos, Mina Grande, and Haciendita were all located six miles (10 kilometers) north of El Gallo, and the fourth vein, San Dimas, is located 6 miles (10 kilometers) south of El Gallo.
Advisors' Opinion:- [By Jake L'Ecuyer]
Leading and Lagging Sectors
In trading on Wednesday, basic materials shares were relative leaders, up on the day by about 0.27 percent. Meanwhile, top gainers in energy sector included Endeavour Silver (NYSE: EXK), with shares up 4.3 percent, and McEwen Mining (NYSE: MUX), with shares up 4.4 percent. - [By Jake L'Ecuyer]
McEwen Mining (NYSE: MUX) was also down, falling 4.35 percent to $2.42 following a Seeking Alpha article commenting on news of an Argentinian taxation raid on mining companies Johnson Controls (NYSE: JCI) was down, falling 2.31 percent to $41.55.
Top 5 Low Price Companies To Watch For 2014: Oak Ridge Energy Technologies Inc (OKME)
Oak Ridge Energy Technologies, Inc., formerly Oak Ridge Micro-Energy, Inc., incorporated on August 15, 1986, is a development-stage company. The Company licenses thin-film, solid-state batteries for industrial, government, and medical applications. The Company�� thin-film battery is rechargeable, lithium-based, and the active battery layers are thinner than common plastic wrap.
The Company�� batteries are intended for applications, such as wireless smart sensors, which operate in harsh environments, security cards, radio frequency identification (RFID) tags, semiconductor non-volatile memory chips, and implantable medical devices. Its prototype cells on ceramic substrates supplied to customers are 0.024 of an inch (0.62 millimeters) thick. Thin-film lithium and lithium-ion batteries are ideally suited for a variety of applications where a small power source is needed.
The Company competes with Infinite Power Solutions, Inc., Front Edge Technology, Inc., Cymbet Corporation, Teledyne Electronic Technologies, Excellatron and Planar Energy Devices, Inc.
Advisors' Opinion:- [By CRWE]
Today, OKME has surged (+6.67%) up +0.050 at $.800 with 10,090 shares in play thus far (ref. google finance Delayed: 10:52AM EDT July 18, 2013).
Oak Ridge Micro-Energy, Inc. previously reported a strategic US $2.5M investment by Precept Fund Management SPC�� on behalf of Prescient Fund SP into the revitalised US battery company Oak Ridge Micro-Energy.
Mr. Steve Barber, Principal of Precept Investment Management Limited, the investment manager of Precept Fund Management SPC said:
��lobally the energy storage sector is projected to be a US$60 Billion market by 2020. Precept�� $2.5m placement into OKME is a strategic move by the fund to secure a significant share of this exciting company and the growth potential of the battery market. Our opinion is that OKME has a world leading technical and commercial team, a focused business development strategy and the reputation to be a key player in the US and global battery market. OKME is one of only two investment targets the Fund identified after an in-depth analysis of the energy storage market. The other is a Swiss battery company named Leclanche. Precept is a long-term, active participation, value investor, and we look forward to a long and rewarding relationship with OKME.��/p>
- [By CRWE]
Today, OKME has shed (-7.69%) down -0.050 at $.600 with 2,446 shares in play thus far (ref. google finance Delayed: 9:56AM EDT July 15, 2013), but don�� let this get you down.
Oak Ridge Micro-Energy, Inc. previously reported a strategic US $2.5M investment by Precept Fund Management SPC�� on behalf of Prescient Fund SP into the revitalised US battery company Oak Ridge Micro-Energy.
Mr. Steve Barber, Principal of Precept Investment Management Limited, the investment manager of Precept Fund Management SPC said:
��lobally the energy storage sector is projected to be a US$60 Billion market by 2020. Precept�� $2.5m placement into OKME is a strategic move by the fund to secure a significant share of this exciting company and the growth potential of the battery market. Our opinion is that OKME has a world leading technical and commercial team, a focused business development strategy and the reputation to be a key player in the US and global battery market. OKME is one of only two investment targets the Fund identified after an in-depth analysis of the energy storage market. The other is a Swiss battery company named Leclanche. Precept is a long-term, active participation, value investor, and we look forward to a long and rewarding relationship with OKME.��/p>
Top 5 Low Price Companies To Watch For 2014: Invesco Dynamic Credit Opportunities Fund (VTA)
Van Kampen Dynamic Credit Opportunities Fund (the Fund) is a diversified, closed-end management investment company. The Fund focuses to invest primarily in loan and debt instruments (and loan-related or debt-related instruments) (collectively, credit securities) of issuers that operate in a variety of industries and geographic regions located throughout the world. The Fund's investment adviser is Van Kampen Asset Management (the Adviser). The Fund's investment subadviser is Avenue Europe International Management, L.P. (the Subadviser).
The Fund will invest at least 80% of its net assets (including borrowings for investment purposes) in any combination of credit securities, including senior secured floating rate and fixed-rate loans (Senior Loans); second lien or other subordinated or unsecured floating rate and fixed-rate loans or debt, and other debt obligations, including high-yield, high-risk obligations (such as securities that are rated below investment grade by a nationally recognized credit rating organization or unrated securities that are deemed to be of comparable quality). The Fund may also invest up to 20% of its assets in structured products, including collateralized debt and loan obligations (collectively, structured products). The Fund may also invest in swaps, including credit default, total return, index and interest rate swaps. To the extent that the Fund invests in structured products or swaps that adjust exposure to credit securities, such investments will be counted for purposes of the Fund's 80% policy.
The Fund may invest in credit securities of any credit quality, and may invest without limitation in obligations below investment grade. Any of the Fund's investments may be issued by non-stressed, stressed and distressed issuers, including issuers in bankruptcy, provided that with respect to the portion of the Fund's assets to be managed by the Subadviser, the Subadviser will generally not invest in securities that at the time of investment have a total! yield above the applicable Avenue-Credit Thresholds. The Fund may invest in credit securities of any maturity or duration, and although the Fund will not be managed for maturity or duration, given the nature of the Fund's portfolio, the Fund's portfolio will likely have a low average duration (generally, four years or less). In addition, the Fund may invest up to 20% of its assets in equity securities obtained through debt restructurings or bankruptcy proceedings. The Fund may utilize credit securities derivative instruments.
Advisors' Opinion:- [By John Dowdee]
The following 10 funds satisfied all of these conditions:
BlackRock Float Rate Strategies (FRA). This CEF sells at a discount of 3%, which is low compared to an average premium of 2% over the past year. The distribution has been managed at 6.1% and a small amount (less than 10%) has been return of capital (ROC). However, this has not negatively affected net asset value (NAV) so has not been destructive. The fund holds 447 securities, with 90% in floating rate loans. FRA utilizes 27% leverage and has an expense ratio of 1.7%, including interest payments. Eaton Vance Floating Rate (EFR). This CEF sells at a 1% premium, which is low compared to an average premium of 5% over the past year. The distribution is 6.2%, none of which was ROC. The fund holds 800 securities, with 90% in floating rate loans. About 85% of the securities are from U.S. companies. EFR utilizes 35% leverage and has an expense ratio of 1.8% including interest payments. ING Prime Rate Trust (PPR). This CEF sells for a premium of 2%, which is below the average premium of 5%. It has a distribution of 6.8%, none of which was ROC. The fund has 350 holdings, virtually all in senior loans and from US companies. PPR utilizes 29% leverage and has a high expense ratio of 2.1%, including interest payments. Invesco VK Dynamic Credit Opportunities (VTA). This CEF sells for a discount of 5%, which is below the average discount of 1%. It has a distribution of 7.1%, none of which was ROC. The fund has 495 holdings, with 76% in floating rate loans. About 25% of the loans are from non-US companies. VTA utilizes a relatively low 20% leverage but still has a high expense ratio of 2.1%, including interest payments. Invesco VK Senior Income (VVR). This CEF sells for a discount of 1%, which is below the average premium of 3%. It has a distribution of 7.1%, none of which was ROC. The fund has over 500 holdings, with 89% in floating rate loans. Almost all (95%) securities are from US companies. VVR ut - [By Harry Domash, Publisher, DividendDetective and Winning Investing]
If you're worried about rising interest rates then Invesco Dynamic Credit Opportunities, ticker (VTA), invests in below investment-grade floating rate bank loans. In other words, these are called senior loans.
They're bank loans that adjust their payouts based on prevailing interest rates, so if interest rates go up, these loans will pay higher dividends, so this is a good hedge if you are concerned about rising interest rates.
Another one that's really performed, and it's paying a 6.9% yield right now, Guggenheim Strategic Opportunities, ticker (GOF), that's actually Claymore Guggenheim, holds corporate and government backed, that it's mostly investment-grade and it's paying a 10.1% yield right now, which is pretty high. Those are three that I could recommend right now.
Steven Halpern: Well, we really appreciate you joining us today and sharing your expertise. Thank you.
Harry Domash: You're welcome.
Subscribe to the Dividend Detective here...
Top 5 Low Price Companies To Watch For 2014: Cytomedix Inc (CMXI)
Cytomedix, Inc. (Cytomedix), incorporated in April 29, 1998, is a regenerative therapies company marketing and developing products within the United States and internationally .The Company commercializes cell-based technologies that harness the regenerative capacity of the human body to trigger natural healing. The Company is a commercial operation, and a robust clinical pipeline representing a logical extension of its commercial technologies in the evolving field of regenerative medicine. Cytomedix primarily operates in the United States. Its commercial offerings are centered on its point of care platform technologies for the safe and efficient separation of blood and bone marrow to produce platelet based therapies or cell concentrates.
The Company markets and selsl two distinct platelet rich plasma (PRP) technologies, the AutoloGel System for wound care and the Angel concentrated Platelet Rich Plasma (cPRP) Sytem in orthopedic and cardiovascular markets. Its clinical pipeline includes the ALDH, which are cell-based therapies (Bright Cells). In February 2012, the Company acquired Aldagen, Inc.
The AutoloGel System
The AutoloGel System is a point of care device for the production of a platelet based bioactive therapy derived from a small sample of the patient�� own blood. Using the patient�� own platelets as a therapeutic agent, AutoloGel harnesses the body�� natural healing processes to deliver growth factors, chemokines and cytokines known to promote angiogenesis and to regulate cell growth and the formation of new tissue.
Angel Product Line
The Angel concentrated Platelet Rich Plasma (cPRP) System is a multi-functional cell separation device which produces concentrated platelet rich plasma for use in the operating room and clinic and is used in a range of orthopedic and cardiovascular indications. Similar to the AutoloGel System, the Angel System is a point of care device for the production of a concentrated, aseptic platelet! -based bioactive therapy derived from a small sample of the patient�� own blood. The resulting cPRP is applied at the site of injury to promote healing. The Angel product line also includes ancillary products such as phlebotomy and applicator supplies and activAT. activAT is designed to produce autologous thrombin serum from platelet poor plasma and is sold exclusively in Europe and Canada, where it provides a safe alternative to bovine-derived products.
ALDHbr Cell Technology and Development Pipeline
The ALDHbr (Bright Cell) technology is an approach to cell-based regenerative medicine and a logical extension of its commercial technologies in the evolving regenerative medicine market, with potential clinical indications in markets with unmet medical needs such as peripheral arterial disease and ischemic stroke. The Bright Cell technology is in that it utilizes an intracellular enzyme marker to facilitate fractionation of essential regenerative cells from a patient�� bone marrow. The bone marrow fractionation process identifies and isolates active stem and progenitor cells expressing high levels of the enzyme aldehyde dehydrogenase, or ALDH, which is a key enzyme involved in the regulation of gene activities associated with cell proliferation and differentiation.
The Company�� lead product candidate, ALD-401, is an autologous preparation of Bright Cells for the post-acute treatment of ischemic stroke. ALD-401 is being evaluated in the RECOVER-Stroke clinical study, an ongoing 100-patient, double-blind, placebo-controlled Phase 2 study in patients with unilateral, cerebral ischemic stroke with an NIH stroke scale score of less than 22. An additional product candidate, ALD-301, is in clinical development for peripheral arterial disease (PAD), a condition causing reduced flow of blood and oxygen to muscles in the leg. It has completed a Phase 1/2 study of autologous ALD-301 in critical limb ischemia (CLI), a late stage condition caused by PAD. The Phase 2 PACE! (Patient! s with Intermittent Claudication Injected with ALDH Bright Cells) study is an 80 patient, double-blind, placebo-controlled clinical trial intended to demonstrate the safety and efficacy of ALD-301 (Bright Cells) in patients diagnosed with IC.
The Company competes with Harvest Technologies (a subsidiary of Terumo), Biomet, Arteriocyte, and Arthrex.
Advisors' Opinion:- [By Bryan Murphy]
When traders think of post-surgical wound management stocks, they may first think of names like Cytomedix, Inc. (OTCBB:CMXI) or Alliqua Inc. (OTCMKTS:ALQA). And well they should. Both companies have something of a history in the arena. ALQA is the purveyor of SilverSeal and Hydress antibiotic bandages, while CMXI is the developer of the AutoloGel system, which induces an affected patient's on body to do what it's supposed to do if there's a wound that won't heal. Cytomedix also makes the Angel platelet-rich plasma (PRP) delivery system. There's a relatively new name to add to the list of game-changing stocks in wound-management industry, however.... Arch Therapeutics Inc. (OTCBB:ARTH). The company is developing - well, has developed - a product called AC5 that nips post-surgical bleeding in the bud, largely negating the need for other post-surgical bleeding-control measures.
- [By James E. Brumley]
To give credit where it's due, Cytomedix, Inc. (OTCBB:CMXI) and Baxter International Inc. (NYSE:BAX) have both helped shape the landscape of the hemostasis (bleeding control) market with their products, AutoloGel and TISSELL, respectively. Arch Therapeutics Inc. (OTCBB:ARTH) has proverbially taken their concepts "up a notch", however, and its direct solution to a problem that CMXI and BAX can't quite solve may make ARTH the hottest trading candidate in the hemostasis space.
No comments:
Post a Comment